REQUEST A DEMO
Total
USD $0.00
Search more companies

Lineas Especializadas S.A.S. (Colombia)

Main Activities: Pharmacies and Drug Stores
Full name: Lineas Especializadas S.A.S. Profile Updated: May 07, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Spanish Download a sample report

Lineas Especializadas S.A.S. is an enterprise located in Colombia, with the main office in Bucaramanga. The enterprise operates in the Pharmacies and Drug Stores industry. It was incorporated on September 02, 2014. Lineas Especializadas S.A.S. currently employs 9 (2024) people. The company’s latest financial report indicates a net sales revenue increase of 38.54% in 2023. There was a total growth of 58.58% in Lineas Especializadas S.A.S.’s total assets over the same period. In 2023, Lineas Especializadas S.A.S.’s net profit margin increased by 4.68%.

Headquarters
Calle 37 # 25 - 19
Bucaramanga; Santander;

Contact Details: Purchase the Lineas Especializadas S.A.S. report to view the information.

Basic Information
Total Employees:
Purchase the Lineas Especializadas S.A.S. report to view the information.
Outstanding Shares:
Purchase the Lineas Especializadas S.A.S. report to view the information.
Incorporation Date:
September 02, 2014
Key Executives
Purchase this report to view the information.
Legal Representative
Company Performance
Financial values in the chart are available after Lineas Especializadas S.A.S. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency COP. Absolute financial data is included in the purchased report.
Net sales revenue
38.54%
Total operating revenue
38.54%
Net Profit (Loss) for the Period
210.84%
Total assets
58.58%
Total equity
65.23%
Net Profit Margin
4.68%
Return on Equity (ROE)
18.5%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?